Information regarding our 2022/23 admissions cycle

Our updated course listings for the 2022/23 postgraduate admissions cycle will be published at the beginning of October. Applications for 2022 entry will be available shortly after this. Check our how to apply pages for updates.

MSc Advanced Therapy Medicinal Products / Course details

Year of entry: 2021

Coronavirus information for applicants and offer-holders

We understand that prospective students and offer-holders may have concerns about the ongoing coronavirus outbreak. The University is following the advice from Universities UK, Public Health England and the Foreign and Commonwealth Office.

Read our latest coronavirus information

Course description

Advanced therapy medicinal products (ATMPs) are new medical products that use gene therapy, cell therapy, and tissue engineering.

This is a fast paced and rapidly evolving area of medicine which is increasingly being used to treat a broad range of malignant and non-malignant diseases.

Our MSc is designed to equip you, the researchers of tomorrow, with the necessary understanding of the challenges of bringing an ATMP through development and to patients.

This will be achieved not only through the multi-disciplinary nature of the course content but through the range of expertise of the staff delivering the content which includes preclinical development scientists, regulatory professionals, clinicians and oncologists.

Please note the MSc Advanced Therapy Medicinal Products is a postgraduate masters course with a broad content aimed at a range of multi-professional health care professionals such as medics, pharmacists, nurses and science graduates. As such it does not provide any specific post graduate qualification in any one specialist area, that is, graduates of this programme will not graduate with a specialist post graduate pharmacy qualification, nursing qualification etc.


This MSc aims to deliver a broad and comprehensive overview with in-depth insights into the rapidly developing and cutting-edge field of advanced therapies.

You will undergo comprehensive training in all aspects of the field of ATMP development and delivery.

In this unique course, you can choose to follow laboratory based or clinical research-based content with optional modules available covering a wide variety of ATMP indications.

This allows you to diversify depending on your interests and background.

The overall core content available to all students will cover the following:

  • The different types of ATMPs and the clinical indications for their use.
  • The ATMP pathway from preclinical research to clinical trial design, clinical delivery and licencing.
  • The infrastructure requirements for the delivery of ATMPs pre and post licensing.
  • The manufacturing processes for ATMPs.
  • The regulatory framework for clinical trials, marketing authorisation applications and licensing requirements for ATMPs.

Special features

Taught by experts in advanced therapies from across the industry and academia.

You will also have opportunities to interact with and learn from experts within the field of advanced therapies to broaden your knowledge and experience of this rapidly expanding field.

Coursework and assessment

You will use a number of assessed and non-assessed activities to develop key skills and expand your knowledge base.

There are no written exams. Assessment is based on assignments, presentations and other activities such as moderated discussion boards and group work.

Course unit list

The course unit details given below are subject to change, and are the latest example of the curriculum available on this course of study.

TitleCodeCredit ratingMandatory/optional
Laboratory Skills Unit MEDN66111 15 Mandatory
Research Project 1 MEDN66230 60 Mandatory
Research Project 2 MEDN66242 60 Mandatory
Introduction to Advanced Therapy Medicinal (ATMP) products: from the lab to the clinic MEDN69740 15 Mandatory
Designing and delivering an ATMP clinical trial ¿manufacturing and regulatory complexities MEDN69750 15 Mandatory
Research Methods MEDN69910 15 Mandatory

Course collaborators

The following organisations have collaborated with us to develop this course:
  • The Christie Hospital Foundation Trust
  • Immetacyte Ltd
  • Cell and Gene Therapy Catapult
  • Innovate Manchester Advanced Therapy Centre Hub (iMATCH)


The University of Manchester offers extensive library and online services to help you get the most out of your studies.

Disability support

Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: